Astellas Pharma Inc Unsponsored Adr News, Astellas Pharma Inc Unsponsored Adr Quote, ALPMY Quote

Astellas Pharma Inc Unsponsored Adr (OP:ALPMY) Delayed: 13.60 +0.35 (2.64%)

Prev. Close

$13.25

Today 6M 1Y 5Y

Open

$13.46

52 Wk High

$19.40

52 Wk Low

$12.50

Day High

$13.61

Day Low

$13.46

P/E

N/A

EPS

$0.00

Volume

714,315

Friends, Peers and Foes (?): 4503:JP, PFE, ISEE, SGEN, MTSFY (more...)

ALERTS | RSS

Jun 29, 2026 08:29 AM Astellas Pharma Inc (4503:JP) (ALPMY) PT Lowered to JPY2,300 at JPMorgan
Jun 16, 2026 12:22 AM Goldman Sachs Reiterates Buy Rating on Astellas Pharma Inc (4503:JP) (ALPMY)
May 28, 2026 10:37 AM Astellas Pharma Inc (4503:JP) (ALPMY) PT Lowered to JPY2,600 at Macquarie
May 26, 2026 02:45 AM Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable Growth Company
May 18, 2026 08:01 AM Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026
May 14, 2026 10:55 AM "Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies
May 12, 2026 09:04 AM Astellas reports IZERVAY reduced driving eligibility loss risk in eye disease study
May 12, 2026 09:01 AM IZERVAY® (avacincaptad pegol intravitreal solution) Demonstrated Increased Probability of Maintaining Driving Eligibility in Geographic Atrophy Patients
May 4, 2026 12:59 AM Astellas Pharma Inc (4503:JP) (ALPMY) PT Lowered to JPY2,400 at Citi
May 1, 2026 07:15 AM Astellas Pharma Inc (4503:JP) (ALPMY) PT Lowered to JPY2,400 at Citi

Entities mentioned with ALPMY

View All Entities